# AliveDx

> Precision diagnostics and healthcare solutions

> ## Sitemaps
- [XML Sitemap](https://alivedx.com/sitemap_index.xml)

## Key Pages
- Homepage
- About Us
- Products
- Diagnostics Solutions
- Contact

---


## Pages

- [Code of Business Conduct & Ethics](https://alivedx.com/code-of-business-conduct-ethics/)
- [Our Board of Directors](https://alivedx.com/board-of-directors/)
- [Lab customer area](https://alivedx.com/lab-customer-area/)
- [International customer area](https://alivedx.com/international-customer-area/)
- [US customer area](https://alivedx.com/us-customer-area/)
- [Customer login](https://alivedx.com/albacustomerlogin/)
- [Alba OEM Solutions - Contact](https://alivedx.com/alba-oem-solutions-contact/)
- [Alba OEM Solutions](https://alivedx.com/alba-oem-solutions/)
- [Insights center](https://alivedx.com/insights-center/)
- [MosaiQ AiPlex® VAS Assay](https://alivedx.com/mosaiq-aiplex-vas-assay/)
- [MosaiQ AiPlex® APS Assay](https://alivedx.com/mosaiq-aiplex-aps-assay/)
- [MosaiQ's AllergyPlex COMBO Assay](https://alivedx.com/mosaiqs-allergyplex-assay/)
- [LumiQ](https://alivedx.com/lumiq-ifa/)
- [MosaiQ's AiPlex CTDplus Assay](https://alivedx.com/mosaiqs-aiplex-ctdplus-assay/)
- [MosaiQ® AiPlex CD Assay](https://alivedx.com/aiplex-cd/)
- [MosaiQ: Key Features](https://alivedx.com/mosaiq-key-features/)
- [AliveDx Environment](https://alivedx.com/alivedx-environment/)
- [AliveDx Leadership Team](https://alivedx.com/alivedx-leadership-team/)
- [AlbaQ-Chek Simulated Whole Blood Controls](https://alivedx.com/albaq-chek-simulated-whole-blood-controls/)
- [Labassesment form](https://alivedx.com/labassesment-form/)
- [Hiring Process](https://alivedx.com/hiring-process/)
- [Esg principles governance](https://alivedx.com/esg-principles-governance/)
- [Esg principles social policy](https://alivedx.com/esg-principles-social-policy/)
- [Esg principles environment](https://alivedx.com/esg-principles-environment/)
- [Mosaiq inquiry](https://alivedx.com/mosaiq-inquiry/)
- [Investors](https://alivedx.com/investors/)
- [Gender Pay Report](https://alivedx.com/gender-pay-report/)
- [Life at AliveDx](https://alivedx.com/live-at-alivedx/)
- [International products](https://alivedx.com/international-products/)
- [Services](https://alivedx.com/alba-quotient-services/)
- [AliveDx ESG Commitments](https://alivedx.com/esg-policy/)
- [Alba](https://alivedx.com/alba/)
- [Request a consult](https://alivedx.com/request-a-consult/)
- [US Products](https://alivedx.com/us-products/)
- [Media Kit](https://alivedx.com/media-kit/)
- [Careers](https://alivedx.com/careers/)
- [Contact Us](https://alivedx.com/contact/)
- [Solution](https://alivedx.com/solutions/)
- [Who We Are](https://alivedx.com/who-we-are/)
- [Homepage](https://alivedx.com/)

---


## Insights Center

- [Celiac Disease Diagnostics and the Future of Autoimmune Testing](https://alivedx.com/insights-center/celiac-disease-diagnostics-and-the-future-of-autoimmune-testing/)
- [Analytical Performance of a Novel, Fully Automated Multiplexed Microarray Immunoassay for the Simultaneous Detection of Anti-PR3, Anti-MPO, and Anti-GBM Autoantibodies](https://alivedx.com/insights-center/analytical-performance-of-a-novel-fully-automated-multiplexed-microarray-immunoassay-for-the-simultaneous-detection-of-anti-pr3-anti-mpo-and-anti-gbm-autoantibodies/)
- [Clinical Performance of a Novel, Fully Automated Multiplexed Immunoassay for the Simultaneous Detection of Anti-PR3, Anti-MPO, and Anti-GBM Autoantibodies in ANCA-Associated Vasculitis and Anti-GBM Disease](https://alivedx.com/insights-center/clinical-performance-of-a-novel-fully-automated-multiplexed-immunoassay-for-the-simultaneous-detection-of-anti-pr3-anti-mpo-and-anti-gbm-autoantibodies-in-anca-associated-vasculitis-and-anti-gbm-di/)
- [Diabetes Diagnostics: The Need for Advanced Autoimmune Testing](https://alivedx.com/insights-center/diabetes-diagnostics-the-need-for-advanced-autoimmune-testing/)
- [Unlock Lab Efficiencies with an AliveDx Evaluation](https://alivedx.com/insights-center/unlock-lab-efficiencies-with-an-alivedx-evaluation/)
- [Multiplexing: Streamline Autoimmune Testing with MosaiQ AiPlex® CTDplus](https://alivedx.com/insights-center/multiplexing-streamline-autoimmune-testing-with-mosaiq-aiplex-ctdplus/)
- [How Machine Learning Is Transforming CTD Diagnosis ](https://alivedx.com/insights-center/how-machine-learning-is-transforming-ctd-diagnosis/)
- [Transforming Vasculitis Diagnostics: Multiplex Microarray Solutions for PR3, MPO & GBM Autoantibodies](https://alivedx.com/insights-center/transforming-vasculitis-diagnostics-multiplex-microarray-solutions-for-pr3-mpo-gbm-autoantibodies/)
- [Unlocking Comprehensive Insights in Autoimmune Diagnostics: The Role of Anti-DFS70 Autoantibodies](https://alivedx.com/insights-center/unlocking-clarity-in-autoimmune-diagnostics/)
- [Machine learning classification based on a 15-autoantibody profile by a fully automated multiplex microarray immunoassay for autoimmune CTD diagnosis](https://alivedx.com/insights-center/machine-learning-classification-based-on-a-15-autoantibody-profile-by-a-fully-automated-multiplexmicroarray-immunoassay-for-autoimmune-ctd-diagnosis/)
- [LumiQ® System Demonstration](https://alivedx.com/insights-center/lumiq-system-demonstration/)
- [MosaiQ® System Demonstration](https://alivedx.com/insights-center/mosaiq-system-demonstration/)
- [Performance characteristics of Automated Immunoassay Microarray prototype detecting Centromere Protein B (CENP-B). AACC2023.](https://alivedx.com/insights-center/performance-characteristics-of-automated-immunoassay-microarray-prototype-detecting-centromere-protein-b-cenp-b-aacc2023/)
- [Performance characteristics of Automated Immunoassay Microarray detecting Anti-Centromere Protein B antibodies. Immunochemistry & Immunopathology 2023.](https://alivedx.com/insights-center/performance-characteristics-of-automated-immunoassay-microarray-detecting-anti-centromere-protein-b-antibodies-immunochemistry-immunopathology-2023/)
- [Performance characteristics of Automated Immunoassay Microarray prototype analyzing simultaneously 11 IgG markers associated with Connective Tissue Diseases. ACR2023.](https://alivedx.com/insights-center/performance-characteristics-of-automated-immunoassay-microarray-prototype-analyzing-simultaneously-11-igg-markers-associated-with-connective-tissue-diseases-acr2023/)
- [Analytical Performance of a Novel Automated Immunoassay Microarray analyzing simultaneously 15 markers associated with Connective Tissue Diseases. IFCC2024.](https://alivedx.com/insights-center/analytical-performance-of-a-novel-automated-immunoassay-microarray-analyzing-simultaneously-15-markers-associated-with-connective-tissue-diseases-ifcc2024/)
- [Automated Immunoassay Microarray for Detecting Bet v 1-Specific IgE: Performance & Findings from ECI 2024](https://alivedx.com/insights-center/automated-immunoassay-microarray-for-detecting-bet-v-1-specific-ige-performance-findings-from-eci-2024/)
- [Analytical Performance of a Novel Automated Immunoassay Microarray analyzing simultaneously 5 markers associated with Celiac Disease. ACG2024.](https://alivedx.com/insights-center/analytical-performance-of-a-novel-automated-immunoassay-microarray-analyzing-simultaneously-5-markers-associated-with-celiac-disease-acg2024/)
- [Analytical Evaluation of Automated Immunoassay Microarray analyzing simultaneously 11 markers associated with Connective Tissue Diseases in a Spanish Reference Laboratory. ADLM2024.](https://alivedx.com/insights-center/analytical-evaluation-of-automated-immunoassay-microarray-analyzing-simultaneously-11-markers-associated-with-connective-tissue-diseases-in-a-spanish-reference-laboratory-adlm2024/)
- [Advances in the Serological Evaluation of Celiac Disease](https://alivedx.com/insights-center/advances-in-the-serological-evaluation-of-celiac-disease/)

---


## Press releases

- [AliveDx announces U.S. Food and Drug Administration (FDA) 510(k) submission for its MosaiQ AiPlex® Vasculitis (VAS) assay.  ](https://alivedx.com/press-releases/alivedx-announces-u-s-food-and-drug-administration-fda-510k-submission-for-its-mosaiq-aiplex-vasculitis-vas-assay/)
- [AliveDx registers MosaiQ®, its Instrument for Multiplex Testing of Autoimmune Diseases, Allergies and Beyond, as a Class II Exempt Device with the U.S. Food and Drug Administration (FDA)](https://alivedx.com/press-releases/alivedx-registers-mosaiq-its-instrument-for-multiplex-testing-of-autoimmune-diseases-allergies-and-beyond-as-a-class-ii-exempt-device-with-the-u-s-food-and-drug-administration-fda/)
- [MosaiQ AiPlex® Vasculitis assay, now available for clinical use in the European Union and other CE mark accepting countries.   ](https://alivedx.com/press-releases/mosaiq-aiplex-vasculitis-assay-now-available-for-clinical-use-in-the-european-union-and-other-ce-mark-accepting-countries/)
- [AliveDx announces US FDA 510(k) submission for MosaiQ AiPlex® Connective Tissue Diseases (CTDplus) multiplex microarray ](https://alivedx.com/press-releases/alivedx-announces-us-fda-510k-submission-for-mosaiq-aiplex-connective-tissue-diseases-ctdplus-multiplex-microarray/)
- [AliveDx announces US FDA 510(k) submission for MosaiQ AiPlex® Celiac Disease (CD) multiplex microarray.  The MosaiQ AiPlex CD is designed to improve the accuracy and speed of celiac disease diagnosis while simplifying laboratory workflows](https://alivedx.com/press-releases/alivedx-announces-us-fda-510k-submission-for-mosaiq-aiplex-celiac-disease-cd-multiplex-microarray-the-mosaiq-aiplex-cd-is-designed-to-improve-the-accuracy-and-speed-of-celiac-disease/)
- [AliveDx Expands Autoimmune Menu with IVDR-CE Marked MosaiQ AiPlex® CTDplus Multiplex Assay to Aid in Diagnosing Systemic Autoimmune Rheumatic Diseases and Streamline Laboratory Workflow](https://alivedx.com/press-releases/alivedx-expands-autoimmune-menu-with-ivdr-ce-marked-mosaiq-aiplex-ctdplus-multiplex-assay-to-aid-in-diagnosing-systemic-autoimmune-rheumatic-diseases-and-streamline-laboratory-workflow/)
- [AliveDx Receives IVDR-CE Mark for Multiplexed Assay to Accurately Detect Celiac Disease (CD) on the MosaiQ® System  ](https://alivedx.com/press-releases/alivedx-receives-ivdr-ce-mark-for-multiplexed-assay-to-accurately-detect-celiac-disease-cd-on-the-mosaiq-system/)
- [AliveDx Announces Turnkey Solution for Precise, Automated Autoimmune Diagnostics](https://alivedx.com/press-releases/alivedx-announces-turnkey-solution-for-precise-automated-autoimmune-diagnostics/)
- [AliveDx Receives IVDR CE Mark for Groundbreaking Microarray Immunoassay in Allergy Diagnostics](https://alivedx.com/press-releases/alivedx-receives-ivdr-ce-mark-for-groundbreaking-microarray-immunoassay-in-allergy-diagnostics/)
- [AliveDx receives IVDR Certification of its Manufacturing Sites in Switzerland and United Kingdom](https://alivedx.com/press-releases/alivedx-receives-ivdr-certification-of-its-manufacturing-sites-in-switzerland-and-united-kingdom/)
- [AliveDx receives three IVDR CE marks for its Multiplexed Autoimmune Diagnostics Solution](https://alivedx.com/press-releases/alivedx-receives-three-ivdr-ce-marks-for-its-multiplexed-autoimmune-diagnostics-solution/)
- [Quotient Limited Selected to Join the World Economic Forum New Champions Community](https://alivedx.com/press-releases/quotient-limited-selected-join-world-economic-forum-new-champions-community/)
- [Quotient Limited Expands MosaiQ Innovator’s Circle to Empower Patient Care and Laboratory Efficiencies](https://alivedx.com/press-releases/quotient-limited-expands-mosaiq-innovators-circle-empower-patient-care-and-laboratory/)
- [Quotient Limited and Theradiag Announce Partnership to Advance Autoimmune Disease Diagnostics](https://alivedx.com/press-releases/quotient-limited-and-theradiag-announce-partnership-advance-autoimmune-disease/)
- [Quotient Limited Announces Opening of Office in Dubai, United Arab Emirates](https://alivedx.com/press-releases/quotient-limited-announces-opening-office-dubai-united-arab-emirates/)
- [Quotient Limited to Host Key Opinion Leader Webinar on its MosaiQ™ Solution](https://alivedx.com/press-releases/quotient-limited-host-key-opinion-leader-webinar-its-mosaiqtm-solution/)
- [Quotient Limited Further Strengthens Scientific and Medical Synergies with the Expansion of the MosaiQ Innovator’s Circle](https://alivedx.com/press-releases/quotient-limited-further-strengthens-scientific-and-medical-synergies-expansion/)
- [Quotient Limited Announces Receipt of CE Mark for the Extended Immunohematology Microarray](https://alivedx.com/press-releases/quotient-limited-announces-receipt-ce-mark-extended-immunohematology-microarray/)
- [Quotient Limited Launches Scientific Advisory Board and Research Programs](https://alivedx.com/press-releases/quotient-limited-launches-scientific-advisory-board-and-research-programs/)
- [Quotient Limited Provides Update on MosaiQ Expanded Immunohematology Microarray CE Marking Progress](https://alivedx.com/press-releases/quotient-limited-provides-update-mosaiq-expanded-immunohematology-microarray-ce/)
- [Quotient Limited Announces Appointment of Chief Manufacturing Operations Officer](https://alivedx.com/press-releases/quotient-limited-announces-appointment-chief-manufacturing-operations-officer/)
- [Quotient Limited Announces Appointment of Chief Financial Officer](https://alivedx.com/press-releases/quotient-limited-announces-appointment-chief-financial-officer/)
- [Quotient Limited Announces Appointment of Chief Commercial Officer](https://alivedx.com/press-releases/quotient-limited-announces-appointment-chief-commercial-officer/)
- [Quotient Limited Provides Update on CE Marking Progress of the MosaiQ™ Expanded Immunohematology Microarray](https://alivedx.com/press-releases/quotient-limited-provides-update-ce-marking-progress-mosaiqtm-expanded/)
- [MosaiQ by Quotient Wins Prestigious Red Dot Design Award](https://alivedx.com/press-releases/mosaiq-quotient-wins-prestigious-red-dot-design-award/)
- [Quotient Limited Announces Manuel Mendez as Chief Executive Officer](https://alivedx.com/press-releases/quotient-limited-announces-manuel-mendez-chief-executive-officer/)
- [Quotient Limited Wins 2021 BIG Innovation Award](https://alivedx.com/press-releases/quotient-limited-wins-2021-big-innovation-award/)
- [Quotient Limited Announces MosaiQ™ Expanded IH EU Field Trial Performance Data](https://alivedx.com/press-releases/quotient-limited-announces-mosaiqtm-expanded-ih-eu-field-trial-performance-data/)
- [Quotient Limited Reports Impressive Results from an Independent SARS-CoV-2 Antibody Detection Study Conducted in Spain](https://alivedx.com/press-releases/quotient-limited-reports-impressive-results-independent-sars-cov-2-antibody-detection/)
- [Quotient Limited and hVIVO Announce Partnership to Support Wide-Spread COVID-19 Antibody Testing in the UK](https://alivedx.com/press-releases/quotient-limited-and-hvivo-announce-partnership-support-wide-spread-covid-19-antibody/)
- [Quotient Limited Announces CE Mark for its SARS-CoV-2 (COVID-19)  Antibody Microarray](https://alivedx.com/press-releases/quotient-limited-announces-ce-mark-its-sars-cov-2-covid-19-antibody-microarray/)
- [Quotient Limited Announces SARS-CoV-2 (COVID-19) Antibody Test Final Performance Data](https://alivedx.com/press-releases/quotient-limited-announces-sars-cov-2-covid-19-antibody-test-final-performance-data/)
- [Quotient Limited Announces SARS-CoV-2 (COVID-19) Antibody Test  Performance Update](https://alivedx.com/press-releases/quotient-limited-announces-sars-cov-2-covid-19-antibody-test-performance-update/)
- [Quotient Limited Announces the Completion of the SARS-CoV-2 Antibody Test Development](https://alivedx.com/press-releases/quotient-limited-announces-completion-sars-cov-2-antibody-test-development/)
- [Quotient Limited Announces CE Mark Approval for Initial Serological Disease Screening Microarray](https://alivedx.com/press-releases/quotient-limited-announces-ce-mark-approval-initial-serological-disease-screening/)
- [Quotient Announces Positive Preliminary Results from the Initial Serological Disease Screening US Field Trial](https://alivedx.com/press-releases/quotient-announces-positive-preliminary-results-initial-serological-disease-screening/)
- [Quotient Limited Announces the Submission of the Initial SDS Microarray CE mark Filing for MosaiQ™](https://alivedx.com/press-releases/quotient-limited-announces-submission-initial-sds-microarray-ce-mark-filing-mosaiqtm/)
- [Quotient Limited Receives European CE Mark for its Initial IH Microarray](https://alivedx.com/press-releases/quotient-limited-receives-european-ce-mark-its-initial-ih-microarray/)
- [Quotient Limited Announces Initial SDS EU Field Trial Performance Data for MosaiQ™](https://alivedx.com/press-releases/quotient-limited-announces-initial-sds-eu-field-trial-performance-data-mosaiqtm/)

---


## News

- [AliveDx Achieves NHS UK Evergreen Level 2 in Annual Sustainability Assessment](https://alivedx.com/news/alivedx-achieves-nhs-uk-evergreen-level-2-in-annual-sustainability-assessment/)
- [AliveDx & Medipac Technologies Ltd: Distribution Agreement Announcement ](https://alivedx.com/news/alivedx-medipac-technologies-ltd-distribution-agreement-announcement/)
- [AliveDx featured in The Guardian newspaper as one of the UK’s Best Workplaces in Biopharma](https://alivedx.com/news/alivedx-featured-in-the-guardian-newspaper-as-one-of-the-uks-best-workplaces-in-biopharma/)
- [AliveDx named one of the UK’s Best Workplaces in BioPharma™ 2025](https://alivedx.com/news/alivedx-named-one-of-the-uks-best-workplaces-in-biopharma-2025/)
- [AliveDx Suisse S.A. & Transmedic sign second distribution agreement for Indonesia, Thailand & Singapore](https://alivedx.com/news/alivedx-suisse-s-a-and-transmedic-sign-second-distribution-agreement-for-indonesia-thailand-and-singapore/)
- [AliveDx Suisse S.A. and Vital Care Production Distribution et Logistique SPA, sign a second distribution agreement for Algeria](https://alivedx.com/news/alivedx-suisse-s-a-and-vital-care-production-distribution-et-logistique-spa-sign-a-second-distribution-agreement-for-algeria/)
- [AliveDx Suisse S.A. and Medical Supplies and Services Co. Ltd. sign a Strategic Distribution Agreement in Saudi Arabia ](https://alivedx.com/news/alivedx-suisse-s-a-and-medical-supplies-and-services-co-ltd-sign-a-strategic-distribution-agreement-in-saudi-arabia/)
- [AliveDx Recertified to ISO 14001 Environmental Standard](https://alivedx.com/news/alivedx-recertified-to-iso-14001-environmental-standard/)
- [AliveDx Earns Great Place To Work Certification™ in its 3 sites: Switzerland, UK and US](https://alivedx.com/news/alivedx-earns-great-place-to-work-certification-in-its-3-sites-switzerland-uk-and-us/)
- [AliveDx Suisse S.A. and Warba Medical Supplies Co. W.L.L sign two strategic distribution agreements in Kuwait](https://alivedx.com/news/alivedx-suisse-s-a-and-warba-medical-supplies-co-w-l-l-sign-two-strategic-distribution-agreements-in-kuwait/)
- [AliveDx Suisse S.A. and Bio-Strategy, part of DKSH Group, sign a distribution agreement for Australia and New Zealand](https://alivedx.com/news/alivedx-suisse-s-a-and-bio-strategy-part-of-dksh-group-sign-a-distribution-agreement-for-australia-and-new-zealand/)
- [Join us at EuroMedLab 2025](https://alivedx.com/news/join-us-at-euromedlab-2025/)
- [AliveDx Suisse S.A. and Disera Tibbi Malzeme Lojistik. san. Tic. A.S sign Distribution Agreement in Türkiye](https://alivedx.com/news/alivedx-suisse-s-a-and-disera-tibbi-malzeme-lojistik-san-tic-a-s-sign-distribution-agreement-in-turkiye/)
- [AliveDx Suisse S.A. and Vital Care SPA sign distribution agreement in Algeria](https://alivedx.com/news/alivedx-suisse-s-a-and-vital-care-spa-sign-distribution-agreement-in-algeria/)
- [Alba Bioscience Limited and Medline Industries, LP sign distribution agreement for Alba reagents in the USA](https://alivedx.com/news/alba-bioscience-limited-and-medline-industries-lp-sign-distribution-agreement-for-alba-reagents-in-the-usa/)
- [Join our webinar with Dr. Gerber Gomez: Multiplex Autoantibody Testing in the Serological Evaluation of Autoimmune Disease](https://alivedx.com/news/join-our-webinar-with-dr-gerber-gomez-multiplex-autoantibody-testing-in-the-serological-evaluation-of-autoimmune-disease/)
- [MosaiQ AiPlex® Celiac Disease (CD) solution obtains Medical Device Authority (MDA) registration in Malaysia](https://alivedx.com/news/mosaiq-aiplex-celiac-disease-cd-solution-obtains-medical-device-authority-mda-registration-in-malaysia/)
- [Alba Bioscience completes UK NHS Evergreen Sustainable Supplier Assessment and achieves Level 2](https://alivedx.com/news/alba-bioscience-completes-uk-nhs-evergreen-sustainable-supplier-assessment-and-achieves-level-2/)
- [Launch of AliveDx Scientific Insights Center](https://alivedx.com/news/launch-of-alivedx-scientific-insights-center/)
- [AliveDx Suisse S.A. and Sedeer Medical Services and Trading Co. LLC Sign Distribution Agreement in Qatar](https://alivedx.com/news/alivedx-suisse-s-a-and-sedeer-medical-services-and-trading-co-llc-sign-distribution-agreement-in-qatar/)
- [MosaiQ AiPlex® Celiac Disease (CD) system now available in the EU market and other geographies that recognize the CE mark](https://alivedx.com/news/mosaiq-aiplex-celiac-disease-cd-system-now-available-in-the-eu-market-and-other-geographies-that-recognize-the-ce-mark/)
- [AliveDx Announces Multiple Evaluation Sites of its MosaiQ® Solution  ](https://alivedx.com/news/alivedx-announces-multiple-evaluation-sites-of-its-mosaiq-solution/)
- [Join us at the upcoming International Friday Meeting](https://alivedx.com/news/join-us-at-the-upcoming-international-friday-meeting/)
- [AliveDx Suisse S.A. and Medikonia Limited Sign Distribution Agreement in Hong Kong and Macau](https://alivedx.com/news/alivedx-suisse-s-a-and-medikonia-limited-sign-distribution-agreement-in-hong-kong-and-macau/)
- [AliveDx Becomes a Member of BIVDA](https://alivedx.com/news/alivedx-becomes-a-member-of-bivda/)
- [AliveDx Suisse S.A. and Bio-State Inc. Sign Distribution Agreement in India](https://alivedx.com/news/alivedx-suisse-s-a-and-bio-state-inc-sign-distribution-agreement-in-india/)
- [Join us at AABB 2024!](https://alivedx.com/news/join-us-at-aabb-2024/)
- [Join us at Medlab Africa!](https://alivedx.com/news/join-us-at-medlab-africa/)
- [AliveDx receives ISO 22301:2019 Certification](https://alivedx.com/news/alivedx-receives-iso-223012019-certification/)
- [AliveDx Receives ISO 13485:2016 and MDSAP Certifications for Its Manufacturing Site in Switzerland, for Both Autoimmune Disease and Allergy Testing](https://alivedx.com/news/alivedx-receives-iso-134852016-and-mdsap-certifications-for-its-manufacturing-site-in-switzerland-for-both-autoimmune-disease-and-allergy-testing/)
- [AliveDx Receives IVDR-CE Mark for Multiplexed Assay to Accurately Detect Celiac Disease (CD) on the MosaiQ® System  ](https://alivedx.com/news/alivedx-receives-ivdr-ce-mark-for-multiplexed-assay-to-accurately-detect-celiac-disease-cd-on-the-mosaiq-system/)
- [Alba Bioscience Inc. Announces Distribution Agreement With RAF Solutions LA, Inc. to Introduce its Blood Bank Reagents in Latin America](https://alivedx.com/news/alba-bioscience-inc-announces-distribution-agreement-with-raf-solutions-la-inc-to-introduce-its-blood-bank-reagents-in-latin-america/)
- [AliveDx Suisse S.A. and Tabrane Pharmaceuticals (PVT) Limited Sign Distribution Agreement in Sri Lanka](https://alivedx.com/news/alivedx-suisse-s-a-and-tabrane-pharmaceuticals-pvt-limited-sign-distribution-agreement-in-sri-lanka/)
- [AliveDx Abstract Wins ADLM 2024 Industry Division Best Abstract Award First Place](https://alivedx.com/news/alivedx-abstract-wins-adlm-2024-industry-division-best-abstract-award-first-place/)
- [AliveDx Suisse S.A. and Kyungil Hi-tec INC Sign Distribution Agreement in South Korea](https://alivedx.com/news/alivedx-suisse-s-a-and-kyungil-hi-tec-inc-sign-distribution-agreement-in-south-korea/)
- [AliveDx Suisse S.A. and PZ Cormay S.A. Sign Distribution Agreement in Poland](https://alivedx.com/news/alivedx-suisse-s-a-and-pz-cormay-s-a-sign-distribution-agreement-in-poland/)
- [Join Us at ADLM 2024](https://alivedx.com/news/join-us-at-adlm-2024/)
- [AliveDx Suisse S.A. and Prolab IVD S.R.L. Sign Distribution Agreement in Romania](https://alivedx.com/news/alivedx-suisse-s-a-and-prolab-ivd-s-r-l-sign-distribution-agreement-in-romania/)
- [AliveDx Suisse S.A. and BioAnalytica S.A. Sign Distribution Agreement for Greece and Cyprus](https://alivedx.com/news/alivedx-suisse-s-a-and-bioanalytica-s-a-sign-distribution-agreement-for-greece-and-cyprus/)
- [AliveDx Suisse S.A. and Axon Lab AG Sign Distribution Agreement for Austria, Germany and Switzerland](https://alivedx.com/news/alivedx-suisse-s-a-and-axon-lab-ag-sign-distribution-agreement-for-austria-germany-and-switzerland/)
- [AliveDx USA Receives Great Place To Work Certification](https://alivedx.com/news/alivedx-usa-receives-great-place-to-work-certification/)
- [Two AliveDx Abstracts Featured in EULAR 2024 Abstract Book](https://alivedx.com/news/two-alivedx-abstracts-featured-in-eular-2024-abstract-book/)
- [AliveDx Switzerland Retains ISO 14001 Certification](https://alivedx.com/news/alivedx-switzerland-retains-iso-14001-certification/)
- [AliveDx Suisse S.A. and Palex Medical S.A.U. Sign Distribution Agreement for Spain](https://alivedx.com/news/alivedx-suisse-s-a-and-palex-medical-s-a-u-sign-distribution-agreement-for-spain/)
- [AliveDx Suisse S.A. and Medical Development Medical Devices W.L.L. Sign Distribution Agreement in the Kingdom of Bahrain](https://alivedx.com/news/alivedx-suisse-s-a-and-medical-development-medical-devices-w-l-l-sign-distribution-agreement-in-the-kingdom-of-bahrain/)
- [AliveDx Suisse S.A. and Lavichem Joint Stock Company Sign Distribution Agreement in North Vietnam](https://alivedx.com/news/alivedx-suisse-s-a-and-lavichem-joint-stock-company-sign-distribution-agreement-in-north-vietnam/)
- [AliveDx Suisse S.A. and Medlinks Consulting Joint Stock Company Sign Distribution Agreement in Vietnam](https://alivedx.com/news/alivedx-suisse-s-a-and-medlinks-consulting-joint-stock-company-sign-distribution-agreement-in-vietnam/)
- [Abstract Accepted by the European Congress of Immunology (ECI 2024)](https://alivedx.com/news/abstract-accepted-by-the-european-congress-of-immunology-eci-2024/)
- [AliveDx Suisse S.A. and Patho Solutions Malaysia Sdn. Bhd. sign Distribution Agreement in Malaysia](https://alivedx.com/news/alivedx-suisse-s-a-and-patho-solutions-malaysia-sdn-bhd-sign-distribution-agreement-in-malaysia/)
- [AliveDx Suisse S.A. and Everlight Biotech Co Ltd. Sign Distribution Agreement in Taiwan](https://alivedx.com/news/alivedx-suisse-s-a-and-everlight-biotech-co-ltd-sign-distribution-agreement-in-taiwan/)
- [Presenting the AliveDx 2023 Sustainability Report](https://alivedx.com/news/presenting-the-alivedx-2023-sustainability-report/)
- [AliveDx Suisse S.A. and Ozgun Kimya A.S. Sign Distribution Agreement in Türkiye](https://alivedx.com/news/alivedx-suisse-s-a-and-ozgun-kimya-a-s-sign-distribution-agreement-in-turkiye/)
- [MosaiQ® AiPlex CTD Solution Now Available in Over 35 Countries](https://alivedx.com/news/mosaiq-aiplex-ctd-solution-now-available-in-over-35-countries/)
- [Bringing AliveDx's ESG Activities and Commitments to Life](https://alivedx.com/news/bringing-alivedxs-esg-activities-and-commitments-to-life/)
- [MosaiQ abstract published in Immunochemistry & Immunopathology Journal](https://alivedx.com/news/mosaiq-abstract-published-in-immunochemistry-immunopathology-journal/)
- [AliveDx and Global Marketing Services sign distribution agreements for Pakistan ](https://alivedx.com/news/alivedx-and-global-marketing-services-sign-distribution-agreements-for-pakistan/)
- [MosaiQ® Abstract Presented at APLAR 2023](https://alivedx.com/news/mosaiq-abstract-presented-at-aplar-2023/)
- [AliveDx and Bio-Strategy sign distribution agreements for Australia, New Zealand, and the Pacific Islands](https://alivedx.com/news/alivedx-and-bio-strategy-sign-distribution-agreements-for-australia-new-zealand-and-the-pacific-islands/)
- [Unveiling The L.I.V.E Xchange showroom and innovation space](https://alivedx.com/news/unveiling-the-l-i-v-e-xchange-showroom-and-innovation-space/)
- [AliveDx and Rowad Medical Services sign distribution agreement in the Kingdom of Saudi Arabia](https://alivedx.com/news/alivedx-and-rowad-medical-services-sign-distribution-agreement-in-the-kingdom-of-saudi-arabia/)
- [AliveDx held its first Golden Partners Meeting](https://alivedx.com/news/alivedx-held-its-first-golden-partners-meeting/)
- [MosaiQ® Abstract Presented at Annual ACR Convergence Meeting](https://alivedx.com/news/mosaiq-abstract-presented-at-annual-acr-convergence-meeting/)
- [AliveDx receives three IVDR CE marks for its Multiplexed Autoimmune Diagnostics Solution](https://alivedx.com/news/alivedx-receives-three-ivdr-ce-marks-for-its-multiplexed-autoimmune-diagnostics-solution/)
- [Unveiling an Exciting Rebranding Initiative: AliveDx](https://alivedx.com/news/unveiling-an-exciting-rebranding-initiative-alivedx/)
- [Quotient Announces FDA Registration for ALBA Elution Kit](https://alivedx.com/news/quotient-announces-fda-registration-alba-elution-kit/)
- [Alba by Quotient Portfolio Now Available in the Czech Republic](https://alivedx.com/news/alba-quotient-portfolio-now-available-czech-republic/)
- [Quotient Announces ALBA Elution Kit is now CE Marked](https://alivedx.com/news/uotient-announces-alba-elution-kit-now-ce-marked/)
- [MosaiQ abstract presented at the Dresden Symposium on Autoantibodies](https://alivedx.com/news/mosaiq-abstract-presented-dresden-symposium-autoantibodies/)
- [Quotient and FAS Diagnostic Group, Inc. sign distribution agreement in the Philippines](https://alivedx.com/news/quotient-and-fas-diagnostic-group-inc-sign-distribution-agreement-philippines/)
- [Visit us at Medlab Asia 2023!](https://alivedx.com/news/visit-us-medlab-asia-2023/)
- [Quotient is becoming AliveDx](https://alivedx.com/news/quotient-becoming-alivedx/)
- [MosaiQ abstract accepted to AACC Congress](https://alivedx.com/news/mosaiq-abstract-accepted-aacc-congress/)
- [Quotient Suisse SA Achieves Annual ISO 14001 Certification](https://alivedx.com/news/quotient-suisse-sa-achieves-annual-iso-14001-certification/)
- [Quotient and Transmedic sign distribution agreement in Southeast Asia](https://alivedx.com/news/quotient-and-transmedic-sign-distribution-agreement-southeast-asia/)
- [Alba by Quotient™ portfolio now available in additional European markets](https://alivedx.com/news/alba-quotienttm-portfolio-now-available-additional-european-markets/)
- [Abstract Submission Accepted at EULAR Annual Meeting](https://alivedx.com/news/quotient-abstract-submission-accepted-eular-annual-meeting/)
- [ALBA receives product group certification for Class C Blood Grouping Reagents under new IVDR standards.](https://alivedx.com/news/alba-receives-product-group-certification-class-c-blood-grouping-reagents-under-new-ivdr/)
- [Alba by Quotient™ Now Available in Germany, France, Luxembourg, Austria and Slovakia!](https://alivedx.com/news/alba-quotienttm-now-available-germany-france-luxembourg-austria-and-slovakia/)
- [Quotient Limited Selected to Join the World Economic Forum New Champions Community](https://alivedx.com/news/quotient-limited-selected-join-world-economic-forum-new-champions-community/)
- [MosaiQ by Quotient Wins Prestigious Red Dot Design Award](https://alivedx.com/news/mosaiq-quotient-wins-prestigious-red-dot-design-award/)
- [Quotient Limited Wins 2021 BIG Innovation Award](https://alivedx.com/news/quotient-limited-wins-2021-big-innovation-award/)

---

> ## FAQs
- **What does AliveDx specialize in?**  
  AliveDx provides advanced diagnostic solutions for precision healthcare.

- **Where can I find product information?**  
  Visit Products for detailed specifications.

- **How do I contact AliveDx?**  
  Use our Contact page for inquiries.

- **Does AliveDx offer scientific resources?**  
  Yes, explore our Insights Center for blogs, case studies, and industry updates.


---